These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12826232)

  • 1. Curcumin enhances the immunosuppressive activity of cyclosporine in rat cardiac allografts and in mixed lymphocyte reactions.
    Chueh SC; Lai MK; Liu IS; Teng FC; Chen J
    Transplant Proc; 2003 Jun; 35(4):1603-5. PubMed ID: 12826232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 15AU81, a prostacyclin analog, enhances donor-specific hepatocytes to prolong the survival of rat heart but not small bowel allografts.
    Boyle MJ; Dumble LJ
    Cell Transplant; 1999; 8(5):543-8. PubMed ID: 10580348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of unresponsiveness to allografts induced by rapamycin and rapamycin/cyclosporine treatment in rats.
    Ferraresso M; Ghobrial R; Stepkowski SM; Kahan BD
    Transplantation; 1993 Apr; 55(4):888-94. PubMed ID: 8475565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus.
    Wang ME; Tejpal N; Qu X; Yu J; Okamoto M; Stepkowski SM; Kahan BD
    Transplantation; 1998 Apr; 65(7):899-905. PubMed ID: 9565092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunosuppressive action of suppressor cells from antigen-cyclosporine-treated hosts on renal allograft survival.
    Yoshimura N; Kahan BD
    Transplantation; 1985 Oct; 40(4):384-9. PubMed ID: 2413593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive effects of defibrotide.
    Ferraresso M; Rigotti P; Stepkowski SM; Chou TC; Kahan BD
    Transplantation; 1993 Oct; 56(4):928-33. PubMed ID: 8212219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel immunomodulator KRP-203 combined with cyclosporine prolonged graft survival and abrogated transplant vasculopathy in rat heart allografts.
    Takahashi M; Shimizu H; Murakami T; Enosawa S; Suzuki C; Takeno Y; Hakamata Y; Kudou S; Izawa S; Yasue T; Kobayashi E
    Transplant Proc; 2005; 37(1):143-5. PubMed ID: 15808575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection.
    Stepkowski SM; Tian L; Napoli KL; Ghobrial R; Wang ME; Chou TC; Kahan BD
    Clin Exp Immunol; 1997 Apr; 108(1):63-8. PubMed ID: 9097913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models.
    Nikolova Z; Hof A; Baumlin Y; Hof RP
    Transpl Immunol; 2001 Feb; 8(4):267-77. PubMed ID: 11316070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
    Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
    Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor-specific tolerance by perioperative intrathymic injection of bone marrow cells in the rat cardiac allograft model: use of FK506 can shorten the necessary duration of pretransplant intrathymic conditioning.
    Ito A; Ito T; Kamiike W; Moriguchi A; Ohkawa A; Uchikoshi F; Tanaka S; Nakata S; Matsuda H
    Transplantation; 1997 Sep; 64(5):752-7. PubMed ID: 9311715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of tolerance toward rat cardiac allografts by treatment with allochimeric class I MHC antigen and FTY720.
    Chueh SC; Tian L; Wang M; Wang ME; Stepkowski SM; Kahan BD
    Transplantation; 1997 Nov; 64(10):1407-14. PubMed ID: 9392303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressor cell activity of cells infiltrating rat renal allografts prolonged by perioperative administration of extracted histocompatibility antigen and cyclosporine.
    Yoshimura N; Kahan BD
    Transplantation; 1985 Dec; 40(6):708-13. PubMed ID: 2933856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of transforming growth factor-beta and profibrogenic molecules in a rat cardiac allograft model treated with cyclosporine.
    Khanna AK; Hosenpud JS; Plummer MS; Hosenpud JD
    Transplantation; 2002 May; 73(10):1543-9. PubMed ID: 12042638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic immunosuppressive actions of cyclosporine with a mouse anti-rat alpha/beta-T cell receptor monoclonal antibody.
    Knight RJ; Kurrle R; Stepkowski S; Serino F; Chou TC; Kahan BD
    Transplantation; 1994 Jun; 57(11):1544-8. PubMed ID: 8009587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrasplenic liver parenchymal cells in conjunction with low-dose rapamycin and cyclosporine induce a unique and specific prolongation of rat cardiac and small bowel allograft survival.
    Boyle MJ; Baghdassarian V; Stepkowski SM; Dumble LJ; Kahan BD
    Cell Transplant; 1998; 7(3):247-56. PubMed ID: 9647434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the pharmacokinetic interaction between orally administered sirolimus and cyclosporine on the synergistic prolongation of heart allograft survival in rats.
    Stepkowski SM; Napoli KL; Wang ME; Qu X; Chou TC; Kahan BD
    Transplantation; 1996 Oct; 62(7):986-94. PubMed ID: 8878394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief cyclosporine treatment prevents intrathymic (IT) tolerance induction and precipitates acute rejection in an IT rat cardiac allograft model.
    Smith CR; Mohanakumar T; Shimizu Y; Yu S; Otomo N; Kaleem Z; Flye MW
    Transplantation; 2000 Jan; 69(2):294-9. PubMed ID: 10670641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
    Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
    Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of a clinically relevant protocol to induce tolerance of cardiac allografts. Perioperative donor spleen cells plus cyclosporine suppress IL-2 and interferon-gamma production.
    Salom RN; Maguire JA; Hancock WW
    Transplantation; 1993 Dec; 56(6):1309-14. PubMed ID: 8278994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.